Mucosal vaccination in mice provides protection from diverse respiratory threats
Science · 2026
DOI: 10.1126/science.aea1260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, 2026. Verfasst von Haibo Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford University, Stanford, CA, USA. Hauptthemen laut MEDLINE: Bacterial Vaccines, COVID-19, Viral Vaccines. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Open Philanthropy.
Abstract (Originalsprache)
Traditional vaccines target specific pathogens, limiting their scope against diverse respiratory threats. We describe an intranasal liposomal formulation combining toll-like receptor 4 and 7/8 ligands with a model antigen, ovalbumin, which provided broad, durable protection in mice for at least 3 months against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Staphylococcus aureus . In addition, the vaccine protected mice from other viruses (SARS-CoV-2, SARS, SHC014 coronavirus), bacteria ( Acinetobacter baumannii ), and allergens. Protection was mediated by persistent ovalbumin-specific CD4 + and CD8 + memory T cells that imprinted alveolar macrophages (AMs), enhancing antigen presentation and antiviral immunity. Following infection, vaccinated mice mounted rapid pathogen-specific T cell and antibody responses and formed ectopic lymphoid structures in the lung. These results reveal a class of “universal vaccines” against diverse respiratory threats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford University, Stanford, CA, USA.
- Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory Vaccine Center, Emory National Primate Research Center, Emory University School of Medicine, Atlanta, GA,…
- Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Access to Advanced Health Institute (AAHI), Seattle, WA, USA.
- University of Washington, Department of Global Health, Seattle, WA, USA.
- Department of Immunobiology, University of Arizona, Tucson, AZ, USA.
ORCID-Profile: Haibo Zhang, Katharine Floyd, Zhuoqing Fang, Filipe Araujo Hoffmann, Audrey Lee, Heather Marie Froggatt, Xia Xie, Haleigh B Eppler, Jordan Mariah Santagata, Yanli Wang, Mengyun Hu, Prabhu S Arunachalam, Ralph Baric, Mehul S Suthar, Bali Pulendran
Förderung
- NIAID NIH HHS
- Open Philanthropy
Zitieren
APA
Zhang, H., Floyd, K., Fang, Z., Hoffmann, F. A., Lee, A., Froggatt, H. M., Bharj, G., Xie, X., Eppler, H. B., Santagata, J. M., Wang, Y., Hu, M., Fox, C. B., Arunachalam, P. S., Baric, R., Suthar, M. S., & Pulendran, B. (2026). Mucosal vaccination in mice provides protection from diverse respiratory threats. Science. https://doi.org/10.1126/science.aea1260
Vancouver
Zhang H, Floyd K, Fang Z, Hoffmann FA, Lee A, Froggatt HM, et al. Mucosal vaccination in mice provides protection from diverse respiratory threats. Science. 2026. doi:10.1126/science.aea1260
BibTeX
@article{Zhang2026,
author = {Zhang, Haibo and Floyd, Katharine and Fang, Zhuoqing and Hoffmann, Filipe Araujo and Lee, Audrey and Froggatt, Heather Marie and Bharj, Gurpreet and Xie, Xia and Eppler, Haleigh B and Santagata, Jordan Mariah and Wang, Yanli and Hu, Mengyun and Fox, Christopher B and Arunachalam, Prabhu S and Baric, Ralph and Suthar, Mehul S and Pulendran, Bali},
title = {Mucosal vaccination in mice provides protection from diverse respiratory threats},
journal = {Science},
year = {2026},
doi = {10.1126/science.aea1260}
}
EUVIMED